Details

---

• Manufacturer: Astellas Pharma Europe B.V., Netherlands

• Registration in Malaysia: MAL20091914AZ

Content

• Active Ingredient: Each tablet contains 400 mcg of tamsulosin hydrochloride, equivalent to 367 mcg of tamsulosin.

• Formulation: Prolonged-release, film-coated tablets designed for once-daily administration.

• Manufacturer: Astellas Pharma Europe B.V., Netherlands.

• Registration in Malaysia: MAL20091914AZ.

Indications

• Primary Use: Management of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

• Additional Use: Medical management of ureteral stones (≤1 cm) and post-extracorporeal shock wave lithotripsy (ESWL).

Instructions for Use

• Dosage: Take 1 tablet daily, preferably at the same time each day.

• Administration: Swallow the tablet whole; do not chew, crush, or split, as this may interfere with the prolonged-release mechanism.

• With or Without Food: Can be taken with or without food.

• Missed Dose: If a dose is missed, take it as soon as possible unless it's almost time for the next dose. Do not double doses.

• Renal and Hepatic Impairment: No dose adjustment is required for mild to moderate renal or hepatic impairment.